Yale and Gilead Sciences Sign $40 Million Pact in Search for Cancer Drugs
School of Medicine are joining forces in the latest collaboration between industry and academia to hunt for new drugs. Gilead, known mostly for its line of medicines for HIV/AIDS, will pay $ 40 million for a four-year effort that could be extended to 10
Moreover Technologies – Search results for… drugs – 30 of 1242 returned
Leave a Reply
You must be logged in to post a comment.